Skip to main content
PegBio Co., Ltd. logo

PegBio Co., Ltd. — Investor Relations & Filings

Ticker · 2565 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 2,123 across all filing types
Latest filing 2025-04-24 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 2565

About PegBio Co., Ltd.

http://www.pegbio.com

PegBio Co., Ltd. is a biotechnology company specializing in the in-house discovery and development of innovative therapies for chronic diseases, primarily focusing on the endocrine and metabolic fields. The company leverages its proprietary HECTORTM technology system to design and screen novel molecular entities, including peptide, protein, and small-molecule drugs, targeting unmet clinical needs. PegBio's robust pipeline addresses major chronic conditions such as Type 2 Diabetes (T2DM), obesity, and metabolic dysfunction-associated steatohepatitis (MASH). Key pipeline assets include long-acting GLP-1 receptor agonists, such as Vepinatide, developed for T2DM treatment and weight management. The company emphasizes creating complementary, multi-benefit product pipelines characterized by new targets, new sites, and new mechanisms of action.

Recent filings

Filing Released Lang Actions
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares Classification · 1% confidence The document is a formal Exchange ‘Next Day Disclosure Return’ (FF305) under Hong Kong Listing Rules showing detailed share repurchase transactions and changes in issued and treasury shares. It is a report of the company’s own share buyback activity rather than a corporate narrative, earnings release, or AGM material. This matches the definition of Transaction in Own Shares (POS).
2025-04-24 English
DISCLOSEABLE TRANSACTION IN RELATION TO SUBSCRIPTION AND ACQUISITION OF PREFERENCE SHARES
Capital/Financing Update Classification · 1% confidence The document is an announcement under the Hong Kong Listing Rules disclosing a “disclosable transaction” involving the Company’s subscription for and acquisition of US dollar-denominated preference shares. It details the subscription amount, acquisition price, applicable Listing Rules percentages, and Board approvals. This is not a financial statement, call transcript, AGM material, board change, dividend notice, M&A takeover, or share buyback. Instead, it reports a financing-related transaction (investment in preference shares), which falls under capital/financing updates. Therefore, it is best classified as a Capital/Financing Update (CAP).
2025-04-24 English
NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS AND REQUEST FORM
Report Publication Announcement Classification · 1% confidence The document is a notification letter to non-registered shareholders informing them that the Company’s Annual Report 2024 is now available on the Company’s and the Stock Exchange’s websites. It does not contain the annual report itself, but merely announces its publication and provides a request form for printed copies. This matches the definition of a “Report Publication Announcement” (RPA), which covers announcements regarding the release or availability of company reports.
2025-04-24 English
NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND CHANGE REQUEST FORM
Report Publication Announcement Classification · 1% confidence The document is a notification letter informing shareholders that the Annual Report 2024 is now available on the company’s website and providing instructions on how to request printed copies or change communication preferences. It does not contain the report itself but announces the publication of the report. This matches the definition of a Report Publication Announcement (RPA).
2025-04-24 English
Annual Report 2024
Annual Report Classification · 1% confidence The document is explicitly titled 'ANNUAL REPORT 2024' for CMBC Capital Holdings Limited. It contains comprehensive sections including the Chairman's Statement, Management Discussion and Analysis, Corporate Governance Report, Environmental, Social and Governance Report, and full audited financial statements (Consolidated Statement of Profit or Loss, Financial Position, etc.). This meets the definition of a full annual report. FY 2024
2025-04-24 English
NEXT DAY DISCLOSURE RETURN
Transaction in Own Shares Classification · 1% confidence The document is an HKEx Form FF305 “Next Day Disclosure Return” detailing changes in issued shares, treasury shares, and specific on-market share repurchases (dates, quantities, prices, aggregate cost) under Listing Rules. This is a regulatory report of the company buying back its own shares. This corresponds to the “Transaction in Own Shares” category.
2025-04-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.